Singular Health Raises Capital Through Exercise of Unlisted Options

Singular Health Group Ltd ( (AU:SHG) ) has shared an announcement.

Singular Health Group has issued 272,728 new fully paid ordinary shares following the exercise of an equivalent number of unlisted options priced at $0.10 and expiring in June 2026, raising $27,272.80 in additional capital. The company confirmed the shares were issued without a prospectus under existing Corporations Act provisions, stated it is compliant with its continuous disclosure and reporting obligations, and disclosed there is no excluded information that would need to be revealed to investors under the Act.

The most recent analyst rating on (AU:SHG) stock is a Hold with a A$0.22 price target. To see the full list of analyst forecasts on Singular Health Group Ltd stock, see the AU:SHG Stock Forecast page.

More about Singular Health Group Ltd

Singular Health Group Ltd is a Western Australian, ASX-listed medical technology company focused on unlocking the full value of medical imaging records to create a more integrated healthcare ecosystem. Its flagship 3Dicom software suite helps patients and clinicians better visualise, communicate and understand imaging data, with 3Dicom MD cleared for diagnostic use in the United States.

Average Trading Volume: 486,038

Technical Sentiment Signal: Hold

Current Market Cap: A$77.34M

For detailed information about SHG stock, go to TipRanks’ Stock Analysis page.